APOE and Alzheimer disease: After adjusting for the ApoE4 genotype, both the LDL size and Lp-PLA relative activity remained significantly lower in the AD group when compared to IHC-CAA (OR: 0.55 [0.331–0.912], p = 0.021; OR: 0.962 [0.925–1], p = 0.049 (Supplemental Table S5).